vs
Side-by-side financial comparison of Dorman Products, Inc. (DORM) and Enovis CORP (ENOV). Click either name above to swap in a different company.
Enovis CORP is the larger business by last-quarter revenue ($589.2M vs $528.8M, roughly 1.1× Dorman Products, Inc.). Dorman Products, Inc. runs the higher net margin — 8.2% vs -1.4%, a 9.7% gap on every dollar of revenue. On growth, Enovis CORP posted the faster year-over-year revenue change (5.4% vs 4.2%). Over the past eight quarters, Enovis CORP's revenue compounded faster (5.9% CAGR vs 2.5%).
Dorman Products is an American manufacturer of aftermarket automotive products in the United States. The company was founded in 1918. The company trades on the NASDAQ under the ticker DORM. The company is headquartered in Colmar, Pennsylvania.
Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.
DORM vs ENOV — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $528.8M | $589.2M |
| Net Profit | $43.6M | $-8.4M |
| Gross Margin | 36.0% | 62.0% |
| Operating Margin | 11.1% | — |
| Net Margin | 8.2% | -1.4% |
| Revenue YoY | 4.2% | 5.4% |
| Net Profit YoY | -24.3% | — |
| EPS (diluted) | $1.43 | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $528.8M | $589.2M | ||
| Q4 25 | $537.9M | $548.9M | ||
| Q3 25 | $543.7M | $564.5M | ||
| Q2 25 | $541.0M | $558.8M | ||
| Q1 25 | $507.7M | — | ||
| Q4 24 | $533.8M | $561.0M | ||
| Q3 24 | $503.8M | $505.2M | ||
| Q2 24 | $503.0M | $525.2M |
| Q1 26 | $43.6M | $-8.4M | ||
| Q4 25 | $11.6M | $-571.1M | ||
| Q3 25 | $76.4M | $-36.7M | ||
| Q2 25 | $58.7M | $-56.0M | ||
| Q1 25 | $57.5M | — | ||
| Q4 24 | $54.5M | $-703.2M | ||
| Q3 24 | $55.3M | $-31.5M | ||
| Q2 24 | $47.4M | $-18.6M |
| Q1 26 | 36.0% | 62.0% | ||
| Q4 25 | 42.6% | 59.9% | ||
| Q3 25 | 44.4% | 59.3% | ||
| Q2 25 | 40.6% | 59.5% | ||
| Q1 25 | 40.9% | — | ||
| Q4 24 | 41.5% | 54.8% | ||
| Q3 24 | 40.5% | 56.7% | ||
| Q2 24 | 39.6% | 55.0% |
| Q1 26 | 11.1% | — | ||
| Q4 25 | 5.8% | -101.7% | ||
| Q3 25 | 19.4% | -3.0% | ||
| Q2 25 | 15.2% | -8.4% | ||
| Q1 25 | 15.8% | — | ||
| Q4 24 | 16.3% | -118.5% | ||
| Q3 24 | 15.7% | -6.3% | ||
| Q2 24 | 14.4% | -8.4% |
| Q1 26 | 8.2% | -1.4% | ||
| Q4 25 | 2.1% | -104.1% | ||
| Q3 25 | 14.1% | -6.5% | ||
| Q2 25 | 10.9% | -10.0% | ||
| Q1 25 | 11.3% | — | ||
| Q4 24 | 10.2% | -125.4% | ||
| Q3 24 | 11.0% | -6.2% | ||
| Q2 24 | 9.4% | -3.5% |
| Q1 26 | $1.43 | $-0.15 | ||
| Q4 25 | $0.38 | $-9.99 | ||
| Q3 25 | $2.48 | $-0.64 | ||
| Q2 25 | $1.91 | $-0.98 | ||
| Q1 25 | $1.87 | — | ||
| Q4 24 | $1.76 | $-12.69 | ||
| Q3 24 | $1.80 | $-0.58 | ||
| Q2 24 | $1.53 | $-0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.1M | $33.1M |
| Total DebtLower is stronger | $440.0M | $1.3B |
| Stockholders' EquityBook value | $1.5B | $1.5B |
| Total Assets | $2.4B | $3.8B |
| Debt / EquityLower = less leverage | 0.30× | 0.90× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $43.1M | $33.1M | ||
| Q4 25 | $49.4M | $33.6M | ||
| Q3 25 | $55.5M | $44.1M | ||
| Q2 25 | $56.8M | $38.5M | ||
| Q1 25 | $60.6M | — | ||
| Q4 24 | $57.1M | $48.2M | ||
| Q3 24 | $45.1M | $35.4M | ||
| Q2 24 | $47.5M | $35.0M |
| Q1 26 | $440.0M | $1.3B | ||
| Q4 25 | $440.6M | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | — | ||
| Q4 24 | $468.8M | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B |
| Q1 26 | $1.5B | $1.5B | ||
| Q4 25 | $1.5B | $2.0B | ||
| Q3 25 | $1.5B | $2.6B | ||
| Q2 25 | $1.4B | $2.6B | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | $2.6B | ||
| Q3 24 | $1.2B | $3.3B | ||
| Q2 24 | $1.2B | $3.3B |
| Q1 26 | $2.4B | $3.8B | ||
| Q4 25 | $2.5B | $4.4B | ||
| Q3 25 | $2.6B | $5.0B | ||
| Q2 25 | $2.5B | $4.9B | ||
| Q1 25 | $2.4B | — | ||
| Q4 24 | $2.4B | $4.7B | ||
| Q3 24 | $2.4B | $5.6B | ||
| Q2 24 | $2.3B | $5.4B |
| Q1 26 | 0.30× | 0.90× | ||
| Q4 25 | 0.30× | 0.67× | ||
| Q3 25 | — | 0.54× | ||
| Q2 25 | — | 0.53× | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.36× | 0.52× | ||
| Q3 24 | — | 0.40× | ||
| Q2 24 | — | 0.41× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
